Cardiac Biomarkers Market Segmentation by Top Players, End Users, Products, Application and Region, 2024

 The global Cardiac Biomarkers Market research report provides complete insights on industry scope, global trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready, data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. 

Market Overview: 

The global cardiac biomarkers market size was estimated at USD 4.7 billion in 2015. Cardiac biomarkers are the substances released in the bloodstream due to heart related damage and stress. as a result of insufficient blood supply to the heart. The detection of the biomarkers is used for the identification of various heart conditions such as, acute coronary syndrome, acute myocardial infarction, ischemia, congestive heart failure. 

Key Players:

• Abbott Laboratories
• Alere, Inc.
• Siemens Healthcare GmbH
• Roche Diagnostics Corporation
• Beckman Coulter, Inc.
• Becton, Dickinson &Co. 

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/cardiac-biomarker-market/request-sample 

Growth Drivers: 

Rising prevalence of cardiovascular diseases globally and escalating popularity of POC testing are some of the main factors contributing toward the market growth. 

High prevalence of cardiovascular diseases worldwide has resulted into a significant growth in the cardiac biomarkers market. According to the WHO, about 17.5 million people globally suffer from some heart condition. The increasing preference to the use of the cardiac kits and more awareness among the people regarding the application of the cardiac biomarkers is expected to augment the market in the near future. 

Application Outlook: 

• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure 

Type Outlook: 

• Troponin
• CK-MB
• Natriuretic peptides - BNP and NT-proBNP
• Myoglobin 

Regional Insights: 

The regional market considered in the cardiac biomarkers sector is North America, Europe, Asia Pacific, Latin America, and MEA. North America is estimated to account for the largest revenue share in 2015. The high prevalence of the cardiac disorders in the North America has boosted the application of cardiac biomarkers in North America. Moreover, the increasing popularity of the PoC testing has added to the growth of the market. 

The Asia Pacific region is anticipated to witness fastest growth owing to large population base with target disease. The high prevalence of the cardiovascular diseases has augmented the cardiac biomarker products in the Asia Pacific region. The major emerging markets such as India and China attributes for the major growth in the cardiac biomarker segment in the Asia Pacific region. 

Browse Related Category Research Reports @ https://blog.naver.com/tomclark